Soleno Therapeutics, Inc. (SLNO)
52.94
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:14
Soleno Therapeutics Free Cash Flow : 46.66M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Neurocrine Biosciences, Inc. | 831.30M |
| Nektar Therapeutics | -208.68M |
| Forian, Inc. | 2.886M |
| Boston Scientific Corp. | 3.475B |
| Integer Holdings Corp. | 99.80M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 48.70M |
| Cash from Investing (Quarterly) | -125.36M |
| Cash from Financing (Quarterly) | -99.90M |
| Free Cash Flow Per Share (Quarterly) | 0.8954 |
| Free Cash Flow to Equity (Quarterly) | 48.76M |
| Free Cash Flow to Firm (Quarterly) | 50.00M |
| Free Cash Flow Yield | 1.71% |